Skip to main content
×
Home
    • Aa
    • Aa

The role of autophagy in tumour development and cancer therapy

  • Mathias T. Rosenfeldt (a1) and Kevin M. Ryan (a1)
Abstract

Autophagy is a catabolic membrane-trafficking process that leads to sequestration and degradation of intracellular material within lysosomes. It is executed at basal levels in every cell and promotes cellular homeostasis by regulating organelle and protein turnover. In response to various forms of cellular stress, however, the levels and cargoes of autophagy can be modulated. In nutrient-deprived states, for example, autophagy can be activated to degrade cargoes for cell-autonomous energy production to promote cell survival. In other contexts, in contrast, autophagy has been shown to contribute to cell death. Given these dual effects in regulating cell viability, it is no surprise that autophagy has implications in both the genesis and treatment of malignant disease. In this review, we provide a comprehensive appraisal of the way in which oncogenes and tumour suppressor genes regulate autophagy. In addition, we address the current evidence from human cancer and animal models that has aided our understanding of the role of autophagy in tumour progression. Finally, the potential for targeting autophagy therapeutically is discussed in light of the functions of autophagy at different stages of tumour progression and in normal tissues.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The role of autophagy in tumour development and cancer therapy
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      The role of autophagy in tumour development and cancer therapy
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      The role of autophagy in tumour development and cancer therapy
      Available formats
      ×
Copyright
Re-use permitted under a Creative Commons Licence–by-nc-sa.
Corresponding author
*Corresponding author: Kevin M. Ryan, Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. Tel: +44 1413 303655; Fax: +44 1419 426521; E-mail: k.ryan@beatson.gla.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 J.J. Lum (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248

2 J.J. Lum , R.J. DeBerardinis and C.B. Thompson (2005) Autophagy in metazoans: cell survival in the land of plenty. Nature Reviews Molecular Cell Biology 6, 439-448

3 A. Kuma (2004) The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036

4 N. Mizushima (2008) Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075

5 M.C. Maiuri (2009) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death and Differentiation 16, 87-93

6 M.C. Maiuri (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Reviews Molecular Cell Biology 8, 741-752

7 A.R.J. Young (2009) Autophagy mediates the mitotic senescence transition. Genes and Development 23, 798-803

8 Y. Kondo (2005) The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer 5, 726-734

9 E-L. Eskelinen (2005) Maturation of autophagic vacuoles in Mammalian cells. Autophagy 1, 1-10

10 Z. Xie and D.J. Klionsky (2007) Autophagosome formation: core machinery and adaptations. Nature Cell Biology 9, 1102-1109

11 B. Levine and G. Kroemer (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42

12 S. Diaz-Troya (2008) The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 4, 851-865

13 T. Hara (2008) FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. Journal of Cell Biology 181, 497-510

14 C.H. Jung (2009) ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Molecular Biology of the Cell 20, 1992-2003

15 I.G. Ganley (2009) ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. Journal of Biological Chemistry 284, 12297-12305

16 C. Liang (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nature Cell Biology 8, 688-699

17 C. Liang (2008) Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nature Cell Biology 10, 776-787

18 Y. Ohsumi and N. Mizushima (2004) Two ubiquitin-like conjugation systems essential for autophagy. Seminars in Cell and Developmental Biology 15, 231-236

20 Y. Kabeya (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO Journal 19, 5720-5728

21 D.J. Klionsky (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175

22 Z. Xie , U. Nair and D.J. Klionsky (2008) Atg8 controls phagophore expansion during autophagosome formation. Molecular Biology of the Cell 19, 3290-3298

23 Z. Yang (2006) Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Molecular Biology of the Cell 17, 5094-5104

24 D. Hanahan and R.A. Weinberg (2000) The hallmarks of cancer. Cell 100, 57-70

25 R. Mathew , V. Karantza-Wadsworth and E. White (2007) Role of autophagy in cancer. Nature Reviews Cancer 7, 961-967

26 R. Mathew (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075

27 V. Karantza-Wadsworth (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes and Development 21, 1621-1635

28 R. Mathew (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes and Development 21, 1367-1381

29 S. Jin and E. White (2007) Role of autophagy in cancer: management of metabolic stress. Autophagy 3, 28-31

30 A. Eisenberg-Lerner and A. Kimchi (2009) The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 14, 376-391

31 V.M. Aita (1999) Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59, 59-65

34 X. Qu (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. Journal of Clinical Investigation 112, 1809-1820

36 M. Komatsu (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. Journal of Cell Biology 169, 425-434

37 T. Hara (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889

38 G. Mariño (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. Journal of Biological Chemistry 282, 18573-18583

39 M.S. Kim (2008) Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Human Pathology 39, 1059-1063

40 M.R. Kang (2009) Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. Journal of Pathology 217, 702-706

41 Y. Takahashi (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nature Cell Biology 9, 1142-1151

42 E. Morselli (2009) Anti- and pro-tumor functions of autophagy. Biochimica et Biophysica Acta 1793, 1524-1532

43 S. Pattingre (2008) Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323

44 P.K. Vogt , M. Gymnopoulos and J.R. Hart (2009) PI 3-kinase and cancer: changing accents. Current Opinion in Genetics and Development 19, 12-17

45 D.E. Martin and M.N. Hall (2005) The expanding TOR signaling network. Current Opinion in Cell Biology 17, 158-166

46 D.H. Kim (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175

47 D.D. Sarbassov (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current Biology 14, 1296-1302

48 D.D. Sarbassov (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101

49 A. Toschi (2008) Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. Journal of Biological Chemistry 283, 34495-34499

50 D.A. Guertin and D.M. Sabatini (2007) Defining the role of mTOR in cancer. Cancer Cell 12, 9-22

51 B. Levine , S. Sinha and G. Kroemer (2008) Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4, 600-606

52 M.C. Maiuri (2007) Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO Journal 26, 2527-2539

53 S. Pattingre (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939

54 E. Itakura (2008) Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Molecular Biology of the Cell 19, 5360-5372

56 Y. Zhong (2009) Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nature Cell Biology 11, 468-476

57 K. Matsunaga (2009) Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nature Cell Biology 11, 385-396

59 T.L. Yuan and L.C. Cantley (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510

60 V.P. Krymskaya and E.A. Goncharova (2009) PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects. Cell Cycle 8, 403-413

61 R.J. Shaw and L.C. Cantley (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-430

62 S. Furuta (2004) Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 23, 3898-3904

63 E. Ogier-Denis (2000) Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. Journal of Biological Chemistry 275, 39090-39095

64 S. Pattingre , C. Bauvy and P. Codogno (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. Journal of Biological Chemistry 278, 16667-16674

65 E. Corcelle (2006) Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Research 66, 6861-6870

66 J. Wang (2009) A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. Journal of Biological Chemistry 284, 21412-21424

67 A.K. Rustgi (2007) The genetics of hereditary colon cancer. Genes and Development 21, 2525-2538

68 J. Liang (2007) The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nature Cell Biology 9, 218-224

69 C. Wei (2008) Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling. Clinical Cancer Research 14, 1167-1171

70 D. Gozuacik and A. Kimchi (2006) DAPk protein family and cancer. Autophagy 2, 74-79

71 E. Zalckvar (2009) DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Reports 10, 285-292

72 C. Stevens (2009) Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling. Journal of Biological Chemistry 284, 334-344

73 Y. Yu (2003) Epigenetic regulation of ARHI in breast and ovarian cancer cells. Annals of the New York Academy of Sciences 983, 268-277

75 P. Hainaut and M. Hollstein (2000) p53 and human cancer: the first ten thousand mutations. Advances in Cancer Research 77, 81-137

77 D. Crighton (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121-134

78 Z. Feng (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proceedings of the National Academy of Sciences of the United States of America 102, 8204-8209

79 E. Tasdemir (2008) Regulation of autophagy by cytoplasmic p53. Nature Cell Biology 10, 676-687

80 D. Crighton , S. Wilkinson and K.M. Ryan (2007) DRAM links autophagy to p53 and programmed cell death. Autophagy 3, 72-74

81 J. O'Prey (2009) Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy. Cell Cycle 8, 2260-2265

82 D. Crighton (2007) p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death and Differentiation 14, 1071-1079

83 A.V. Budanov (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600

84 J.M. Rosenbluth (2008) A gene signature-based approach identifies mTOR as a regulator of p73. Molecular and Cellular Biology 28, 5951-5964

85 A.V. Budanov and M. Karin (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460

86 M.C. Maiuri (2009) Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8, 1571-1576

87 E. Morselli (2008) Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 7, 3056-3061

88 W.M. Abida and W. Gu (2008) p53-Dependent and p53-independent activation of autophagy by ARF. Cancer Research 68, 352-357

89 J. Pimkina (2009) ARF induces autophagy by virtue of interaction with Bcl-xl. Journal of Biological Chemistry 284, 2803-2810

90 S. Reef (2006) A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Molecular Cell 22, 463-475

91 S. Courtois-Cox (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10, 459-472

92 M.P. DeYoung (2008) Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes and Development 22, 239-251

93 R.M. Memmott and P.A. Dennis (2009) Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cellular Signalling 21, 656-664

94 J. Brugarolas (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes and Development 18, 2893-2904

95 T.R. Peterson (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873-886

96 S. Shimizu (2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nature Cell Biology 6, 1221-1228

97 L. Yu (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502

99 S. Yousefi (2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nature Cell Biology 8, 1124-1132

100 D.L. Berry and E.H. Baehrecke (2007) Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila. Cell 131, 1137-1148

101 X. Qu (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128, 931-946

102 G. Kroemer and B. Levine (2008) Autophagic cell death: the story of a misnomer. Nature Reviews Molecular Cell Biology 9, 1004-1010

103 A. Prieur and D.S. Peeper (2008) Cellular senescence in vivo: a barrier to tumorigenesis. Current Opinion in Cell Biology 20, 150-155

104 T. Fehm (2008) Tumor cell dormancy: implications for the biology and treatment of breast cancer. APMIS: Acta Pathologica Microbiologica et Immunologica Scandinavica 116, 742-753

105 K. Degenhardt (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64

106 R.K. Amaravadi and C.B. Thompson (2007) The roles of therapy-induced autophagy and necrosis in cancer treatment. Clinical Cancer Research 13, 7271-7279

107 W.X. Zong (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes and Development 18, 1272-1282

108 Z. Jin (2009) Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137, 721-735

109 J. Moscat and M.T. Diaz-Meco (2009) p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001-1004

110 A. Duran (2008) The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13, 343-354

111 R.K. Amaravadi (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. Journal of Clinical Investigation 117, 326-336

112 K.H. Maclean (2008) Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. Journal of Clinical Investigation 118, 79-88

113 M. Komatsu (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884

114 S. Wilkinson (2009) Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity. Genes and Development 23, 1283-1288

115 S. Wilkinson and K.M. Ryan (2009) Growth factor signaling permits hypoxia-induced autophagy by a HIF1alpha-dependent, BNIP3/3L-independent transcriptional program in human cancer cells. Autophagy 5, 1068-1069

116 Y. Nishida (2009) Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461, 654-659

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 19
Total number of PDF views: 152 *
Loading metrics...

Abstract views

Total abstract views: 155 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 30th May 2017. This data will be updated every 24 hours.